Health

    Medical Treatment & Drug Development

    Pandemics & Infectious Diseases

Ph.D

France

2012.09.30

Producing new antimicrobials and enhancing the current drugs polymorphism to fight drug resistance through a new metabolic engineering framework

Affordable, new antibiotics are needed and Cyrille Pauthenier hopes to engineer yeast cells to produce them for us. To avoid toxicity, the process will take place on the outside of the cell, making collection of the new drugs easy and harmless.

TAKING DRUG DESIGN INTO CELLS AND OUT AGAIN

To add or modify information on this page, please contact us at the following address: community.research@axa.com

Cyrille
PAUTHENIER

Institution

Université d'Evry-Val-d'Essonne

Country

France

Nationality

French

Related articles

Health

Pandemics & Infectious Diseases

Chronic & Non Communicable Diseases

AXA Chair

South Africa

2021.11.02

Examining the Relationship Between Syndemics and Societal Change in South Africa

Low- and middle-income countries, particularly those experiencing rapid demographic shifts, are vulnerable to co-occurring pandemics, also known as syndemics, whether... Read more

Lara
DUGAS

University of Cape Town

Health

Medical Treatment & Drug Development

Terresterial Biodiversity

Post-Doctoral Fellowship

Argentina

Harmless and Eco-Friendly Solution as an Alternative to Replace Synthetic Agrochemicals

Agrochemicals were introduced to protect crops from pests and enhance crop yields. However, they have become a long-standing concern due... Read more

Johan
RODRIGUEZ MELO

Instituto de Agrobiotecnología del Litoral

Health

Mental Health & Neurology

Pandemics & Infectious Diseases

Women's Health

AXA Award

Spain

2020.08.31

The Effects of the COVID-19 Pandemic on the Mental Health of Mothers and Newborns

 Early results are expected in less than 12 months and will help bridge a critical gap in research. Indeed, “in... Read more

Maria
FORASTER

ISGlobal Barcelona Institute for Global Health